I. Magnesium Promoted Coupling of Carbodiimides and Terminal Acetylenes, II. Bismuth Compounds Supported by Di(amido) Chelating Ligands

<p>The work presented in this thesis is divided into two parts, both of which investigate the chemistry of main group elements supported by N,N'-donor ligands. Part 1 investigates the use of Mg(mesC{NCy}₂)(N{SiMe₃}₂)(THF) (mes = 2,4,6- Me₃C₆H₃, Cy = C₆H₁₁) as a pre-catalyst for the coupling of terminal acetylenes to carbodiimides. A catalytic cycle for the reaction is proposed, based on a series of stoichiometric reactions. Ligand redistribution via Schlenk equilibria is a prominent feature of the proposed catalytic cycle. The scope of catalysis was also investigated, indicating a strong dependence on the sterics and electronics of both the carbodiimide and the terminal acetylene. Investigation of other magnesium species identified other pathways into the catalytic cycle. Part 2 explores the derivitisation of Bi(Me₂Si{NAr})Cl (Ar = 2,6-i-Pr₂C₆H₃) to form a number of novel bismuth(III) species of the general formula Bi(Me₂Si{NAr})X (X = alkyl, aryl, amide, aryloxide, phosphide). In addition, a number of cationic bismuth species have been isolated from the reaction of Bi(Me₂Si{NAr})Cl with ECl₃ (E = Al, Ga). Preliminary investigations reveal that the amide and aryloxide derivatives are active as initiators for the ring-opening polymerisation of lactide and ε-caprolactone. A number of bismuth(III) compounds bearing the related di(amido)ether ligands [O(Me₂Si{NAr})₂]²⁻ have also been synthesised.</p>

I. Magnesium Promoted Coupling of Carbodiimides and Terminal Acetylenes, II. Bismuth Compounds Supported by Di(amido) Chelating Ligands

<p>The work presented in this thesis is divided into two parts, both of which investigate the chemistry of main group elements supported by N,N'-donor ligands. Part 1 investigates the use of Mg(mesC{NCy}₂)(N{SiMe₃}₂)(THF) (mes = 2,4,6- Me₃C₆H₃, Cy = C₆H₁₁) as a pre-catalyst for the coupling of terminal acetylenes to carbodiimides. A catalytic cycle for the reaction is proposed, based on a series of stoichiometric reactions. Ligand redistribution via Schlenk equilibria is a prominent feature of the proposed catalytic cycle. The scope of catalysis was also investigated, indicating a strong dependence on the sterics and electronics of both the carbodiimide and the terminal acetylene. Investigation of other magnesium species identified other pathways into the catalytic cycle. Part 2 explores the derivitisation of Bi(Me₂Si{NAr})Cl (Ar = 2,6-i-Pr₂C₆H₃) to form a number of novel bismuth(III) species of the general formula Bi(Me₂Si{NAr})X (X = alkyl, aryl, amide, aryloxide, phosphide). In addition, a number of cationic bismuth species have been isolated from the reaction of Bi(Me₂Si{NAr})Cl with ECl₃ (E = Al, Ga). Preliminary investigations reveal that the amide and aryloxide derivatives are active as initiators for the ring-opening polymerisation of lactide and ε-caprolactone. A number of bismuth(III) compounds bearing the related di(amido)ether ligands [O(Me₂Si{NAr})₂]²⁻ have also been synthesised.</p>

Medicinal chemistry and biomedical applications of bismuth-based compounds and nanoparticles

Bismuth-based compounds have been used extensively as medicines for the treatment of gastrointestinal disorders and H. pylori infections. Bismuth compounds and Bi-based nanomaterials show promise for emerging infectious diseases, cancer (e.g.213Bi) and also imaging.

Bismuth nanoparticles obtained by a facile synthesis method exhibit antimicrobial activity against Staphylococcus aureus and Candida albicans

Background Bismuth compounds are known for their activity against multiple microorganisms; yet, the antibiotic properties of bismuth nanoparticles (BiNPs) remain poorly explored. The objective of this work is to further the research of BiNPs for nanomedicine-related applications. Stable Polyvinylpyrrolidone (PVP)-coated BiNPs were produced by a chemical reduction process, in less than 30 min. Results We produced stable, small, spheroid PVP-coated BiNPs with a crystalline organization. The PVP-BiNPs showed potent antibacterial activity against the pathogenic bacterium Staphylococcus aureus and antifungal activity against the opportunistic pathogenic yeast Candida albicans, both under planktonic and biofilm growing conditions. Conclusions Our results indicate that BiNPs represent promising antimicrobial nanomaterials, and this facile synthetic method may allow for further investigation of their activity against a variety of pathogenic microorganisms.